Log in to save to my catalogue

PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer

PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_10386607

PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer

About this item

Full title

PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer

Publisher

London: Nature Publishing Group UK

Journal title

Experimental and Molecular Medicine, 2024, 56(0), , pp.192-209

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Tumor necrosis factor superfamily (TNFSF) resistance contributes to the development and progression of tumors and resistance to various cancer therapies. Tumor-intrinsic alterations involved in the adaptation to the TNFSF response remain largely unknown. Here, we demonstrate that protein kinase C substrate 80K-H (PRKCSH) abundance in lung cancers b...

Alternative Titles

Full title

PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_10386607

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_10386607

Other Identifiers

ISSN

2092-6413,1226-3613

E-ISSN

2092-6413

DOI

10.1038/s12276-023-01147-1

How to access this item